MedPath

Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding

Not Applicable
Completed
Conditions
Depression
Breastfeeding
Interventions
Behavioral: Sunnyside
Behavioral: Sunnyside Plus
Registration Number
NCT04128202
Lead Sponsor
University of Illinois at Chicago
Brief Summary

"SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previously tested "Sunnyside" intervention which targeted skills to manage mood through an interactive website with didactic material and tools. Women in weeks 20-28 of their pregnancy will be randomized to receive either Sunnyside Plus or Sunnyside. The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Sunnyside Plus will include additional education and support to improve breastfeeding outcomes. Breastfeeding education and skills will be provided during the 6 weeks of online lessons during pregnancy. Breastfeeding support will continue through 6 weeks postpartum. This postpartum support will involve weekly online lessons, text support, and video support calls with a Lactation Educator provided on an as-needed basis. SunnysidePlus has the potential to provide a novel paradigm for improving breastfeeding outcomes and preventing depression; one that is accessible, highly scalable and cost-effective.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
22
Inclusion Criteria
  • Female
  • Black or African American
  • 18 years and older
  • Pregnant and between 20 and 28 weeks gestation
  • Intend to breastfeed their child
  • Have a score of 5-14 on the Patient Health Questionnaire-8 (PHQ-8)
  • Have access to a broadband internet connection
  • Are able to read and speak English
Exclusion Criteria
  • Are pregnant with multiples
  • Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
  • Diagnosed with a major depressive episode, psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
  • Are currently receiving treatment (medication or psychotherapy),have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SunnysideSunnysideAn online intervention to better manage mood during and after pregnancy.
Sunnyside PlusSunnyside PlusAn online intervention to better manage mood and promote and support breastfeeding during and after pregnancy.
Primary Outcome Measures
NameTimeMethod
Patient Health Questionnaire-9 (PHQ-9)2 weeks

The PHQ-9 is composed of 9 scored items and 1 unscored item which reflect overall functioning and impairment due to the depressive symptoms. PHQ-9 scoring interpretations are as follows: 1-4: minimal depressive symptoms; 5-9 mild depressive symptoms; 10-14: moderate depressive symptoms; 15-19: moderately severe depressive symptoms: 20-27: severe depressive symptoms.

Breastfeeding StatusThrough 12 weeks postpartum

Breastfeeding initiation, exclusivity, and duration will be assessed in the postpartum period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath